Role of Rapid Molecular Diagnostic Testing in Antimicrobial Stewardship: Effects on Antibiotic De-escalation, Length of Hospital Stay, and Mortality

Authors

  • Sonia Afroz Assistant Professor, Microbiology, Sir Salimullah Medical College (SSMC), Dhaka, Bangladesh Author
  • Rajib Kumar Malakar MBBS, Dinajpur Medical College, Bangladesh Author
  • Shekh Mohammad Mostafa UHFPO, Directorate General of Health Services (DGHS), Bangladesh Author https://orcid.org/0000-0002-9089-3150
  • Prianka Saha MBBS, MPH, Sylhet Women’s Medical College, Bangladesh Author
  • Rafique us Saleheen Assistant Director, Directorate General of Health Services (DGHS), Bangladesh Author
  • Naznin Nahida House Physician, Mayfair Care Center (The Partners Care), New York, USA Author

DOI:

https://doi.org/10.00786/14cg5r58

Keywords:

antimicrobial stewardship , bloodstream infection , rapid molecular diagnostics , antibiotic de-escalation , hospital length of stay , mortality , observational cohort

Abstract

Background: Rapid molecular diagnostics may accelerate antimicrobial optimization in bloodstream infection, but their incremental clinical value in hospitals with existing stewardship services remains uncertain.

Methods: We analysed a nonrandomized cohort from eight anonymised hospitals in the United States between January and December 2023. Of 480 patients, 269 underwent rapid molecular testing and 211 conventional testing; stewardship was present in both groups. The primary endpoint was de-escalation within 72 hours among patients with final susceptibility profiles allowing narrower therapy. Multivariable logistic and gamma regressions adjusted for demographics, comorbidity, critical illness, isolate resistance, effective empirical therapy, and hospital.

Results: Among 416 eligible patients, 72-hour de-escalation occurred in 173/237 (73.0%) rapid-pathway patients versus 25/179 (14.0%) conventional-pathway patients (adjusted odds ratio [aOR] 21.11, 95% CI 11.71–38.04). Median actionable-result time was 18.5 versus 57.6 hours. Broad-spectrum antibiotic days were lower with rapid testing (adjusted mean ratio 0.86, 95% CI 0.80–0.92). Neither post-draw length of stay (adjusted mean ratio 0.92, 95% CI 0.84–1.02) nor 30-day mortality (aOR 0.70, 95% CI 0.36–1.35) differed significantly.

Conclusions: Rapid molecular testing embedded in stewardship was associated with faster de-escalation and reduced broad-spectrum exposure, without demonstrable mortality or length-of-stay benefit. Residual confounding limits causal interpretation.

Downloads

Published

04/25/2024 — Updated on 04/25/2024

Versions

Issue

Section

Articles